Cardiovascular and Circulatory System - Myocardial Infarction Drug Pipeline Report
Posted on: Monday, 16 July 2007, 09:13 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c62797) has announced the addition of Cardiovascular and Circulatory System - Myocardial Infarction Drug Pipeline Report to their offering.
"Cardiovascular and Circulatory System - Myocardial Infarction Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of myocardial infarction drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Content Outline:
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Myocardial Infarction Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Myocardial Infarction Projects
--Top 20 companies in early stage Myocardial Infarction Projects
Full Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c62797
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Raytheon Named to 2009 FORTUNE 25 Top Companies for Leaders List
- Deere & Company Included Among 'Global Top Companies for Leaders'
- Manpower Inc. Named One of PINK Magazine's Top Companies for Women for Second Consecutive Year
- A Metabolic Endocrinology Pipeline Report on Hormone Replacement Therapy, With a Detailed Pipeline Overview and Analysis of Top Companies
- Noble Energy Starts Production From Second Phase of Dumbarton Development
- PSTS China to Commence Production Expansion Project
- Diagnosis: Treatments: Leading Products - Disease and Therapy Review: Alzheimers Disease
- Gain An Insight Into The Pipeline Status Of Melanoma Or Skin Cancer Drugs By Company And By Stage As Well As A Summary Of The Latest News And Developments In This Area
- New Victrex PEEK Film Technology APTIV Product Name Created By Strategic Name Development
- BP May Resume Alaskan Pipeline Production Soon
 |
 |
User Comments (0)
RSS Feeds